{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:20:12Z","timestamp":1783606812571,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12329-1","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:42:15Z","timestamp":1783604535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of anticancer effects of Boswellia serrata extract in combination with SN-38 on U373 GBM cells"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1417-5907","authenticated-orcid":false,"given":"Numan","family":"Taspi\u0307nar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-5103","authenticated-orcid":false,"given":"Sidika","family":"Genc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3506-0324","authenticated-orcid":false,"given":"Ali","family":"Taghizadehghalehjoughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6007-472X","authenticated-orcid":false,"given":"Esmanur","family":"Ni\u0307gde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7052-6086","authenticated-orcid":false,"given":"Kubra","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3844-6158","authenticated-orcid":false,"given":"Rahsan Ilikci","family":"Sagkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"12329_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"12329_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/neuros\/nyaa447_805","volume":"67","author":"SK Tan","year":"2020","unstructured":"Tan SK, Thakur V, Welford S (2020) The polyamine catabolic enzyme SAT1-mediated epigenetic gene regulation and radiation response in GBM. Neurosurgery 67:280\u2013280","journal-title":"Neurosurgery"},{"key":"12329_CR3","doi-asserted-by":"publisher","unstructured":"Wang YX, Zhang S, Sun Q, Yuan FE, Zhao LY, Ye Z, Li Y, Wang RG, Jiang HX, Hu P et al (2021) WAC, a novel GBM tumor suppressor, induces GBM cell apoptosis and promotes autophagy. Med Oncol 38. https:\/\/doi.org\/10.1007\/s12032-021-01580-0. doi:ARTN 132","DOI":"10.1007\/s12032-021-01580-0"},{"key":"12329_CR4","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/S0167-8140(23)89999-6","volume":"186","author":"WL Ong","year":"2023","unstructured":"Ong WL, Stewart J, Sahgal A, Soliman H, Tseng CL, Detsky J, Ho L, Das S, Maralani P, Lipsman N et al (2023) Predictors of tumour dynamics during a six-week Course of chemoradiotherapy for glioblastoma. Radiother Oncol 186:S53\u2013S53","journal-title":"Radiother Oncol"},{"key":"12329_CR5","doi-asserted-by":"publisher","first-page":"116759","DOI":"10.1016\/j.bcp.2025.116759","volume":"233","author":"JS Guo","year":"2025","unstructured":"Guo JS, Wang JY, Chen SH, Deng YP, Gao QY, Liu ZX, Liu J, Lv K, Liu N, Bai GY et al (2025) The natural product micheliolide promotes the nuclear translocation of GAPDH via binding to Cys247 and induces glioblastoma cell death in combination with temozolomide. Biochem Pharmacol 233:116759. https:\/\/doi.org\/10.1016\/j.bcp.2025.116759","journal-title":"Biochem Pharmacol"},{"key":"12329_CR6","doi-asserted-by":"publisher","first-page":"113729","DOI":"10.1016\/j.biopha.2022.113729","volume":"155","author":"L Gaiaschi","year":"2022","unstructured":"Gaiaschi L, Roda E, Favaron C, Gola F, Gabano E, Ravera M, Rossi P, Bottone MG (2022) The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme. Biomed Pharmacother 155:113729. https:\/\/doi.org\/10.1016\/j.biopha.2022.113729","journal-title":"Biomed Pharmacother"},{"key":"12329_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803. https:\/\/doi.org\/10.1021\/acs.jnatprod.9b01285","journal-title":"J Nat Prod"},{"key":"12329_CR8","doi-asserted-by":"publisher","first-page":"14324","DOI":"10.3390\/cimb46120859","volume":"46","author":"L Gaiaschi","year":"2024","unstructured":"Gaiaschi L, Bottone MG, De Luca F (2024) Towards effective treatment of glioblastoma: The role of combination therapies and the potential of phytotherapy and micotherapy. Curr Issues Mol Biol 46:14324\u201314350. https:\/\/doi.org\/10.3390\/cimb46120859","journal-title":"Curr Issues Mol Biol"},{"key":"12329_CR9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1080\/03007995.2020.1758928","volume":"36","author":"CX Shao","year":"2020","unstructured":"Shao CX, He JH, Stein K, Keefe S (2020) Chemotherapy treatments, costs of care, and survival for elderly patients diagnosed with cervical cancer: an observational study. Curr Med Res Opin 36:1187\u20131194. https:\/\/doi.org\/10.1080\/03007995.2020.1758928","journal-title":"Curr Med Res Opin"},{"key":"12329_CR10","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c01274","author":"J Huo","year":"2025","unstructured":"Huo J, Zhang Q, Zhang M, Shi J, Zhang W, Han L, Li Y, Wu X, Jia M, Zheng Y et al (2025) Dual-pronged strike: Curcumin Hijacks FRET amplification and HSP-70 sabotage in an NIR phototheranostic nanoplatform for glioblastoma. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.5c01274","journal-title":"J Med Chem"},{"key":"12329_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-3-319-41334-1_13","volume":"928","author":"HPT Ammon","year":"2016","unstructured":"Ammon HPT (2016) Boswellic acids and their role in chronic inflammatory diseases. Adv Exp Med Biol 928:291\u2013327. https:\/\/doi.org\/10.1007\/978-3-319-41334-1_13","journal-title":"Adv Exp Med Biol"},{"key":"12329_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11060-024-04819-8","volume":"170","author":"TA Barone","year":"2024","unstructured":"Barone TA, Robinson DL, Qiu J, Gurova KV, Purmal AA, Gudkov AV, Plunkett RJ (2024) FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair. J Neurooncol 170:621\u2013630. https:\/\/doi.org\/10.1007\/s11060-024-04819-8","journal-title":"J Neurooncol"},{"key":"12329_CR13","first-page":"1121","volume":"34","author":"Y Shao","year":"2020","unstructured":"Shao Y et al (2020) The antitumor mechanisms of boswellic acids: A review. Phytother Res 34:1121\u20131132","journal-title":"Phytother Res"},{"key":"12329_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.18632\/oncotarget.23182","volume":"9","author":"XF Lu","year":"2018","unstructured":"Lu XF, Zeng D, Liang WQ, Chen CF, Sun SM, Lin HY (2018) FoxM1 is a promising candidate target in the treatment of breast cancer. Oncotarget 9:842\u2013852. https:\/\/doi.org\/10.18632\/oncotarget.23182","journal-title":"Oncotarget"},{"key":"12329_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.23736\/S0026-4806.19.06185-8","volume":"111","author":"XY Hou","year":"2020","unstructured":"Hou XY, Gao BF, Han QT, Wang Q, Liang HY, Huo QQ (2020) Acetyl-11-keto-\u03b2-boswellic acid alleviates myocardial fibrosis injury by inhibiting the TGF-\u03b21\/Smads pathway and activating the Nrf2\/HO-1 pathway. Minerva Med 111:285\u2013288. https:\/\/doi.org\/10.23736\/S0026-4806.19.06185-8","journal-title":"Minerva Med"},{"key":"12329_CR16","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1634\/theoncologist.6-1-66","volume":"6","author":"ML Rothenberg","year":"2001","unstructured":"Rothenberg ML (2001) Irinotecan (CPT-11): Recent developments and future directions-colorectal cancer and beyond. Oncologist 6:66\u201380. https:\/\/doi.org\/10.1634\/theoncologist.6-1-66","journal-title":"Oncologist"},{"key":"12329_CR17","doi-asserted-by":"publisher","unstructured":"Rabelo ACS, Guerreiro CD, Shinzato VI, Ong TP, Noratto G (2023) Anthocyanins reduce cell invasion and migration through Akt\/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: A Systematic Review and Meta-Analysis. Cancers (Basel) 15, ARTN 2300 https:\/\/doi.org\/10.3390\/cancers15082300","DOI":"10.3390\/cancers15082300"},{"key":"12329_CR18","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1517\/17425247.2015.1070142","volume":"12","author":"S Palakurthi","year":"2015","unstructured":"Palakurthi S (2015) Challenges in SN38 drug delivery: current success and future directions. Expert Opin Drug Deliv 12:1911\u20131921. https:\/\/doi.org\/10.1517\/17425247.2015.1070142","journal-title":"Expert Opin Drug Deliv"},{"key":"12329_CR19","doi-asserted-by":"publisher","unstructured":"Yang TC, Liu SJ, Lo WL, Chen SM, Tang YL, Tseng YY (2021) Enhanced anti-tumor activity in mice with temozolomide-resistant human glioblastoma cell line-derived xenograft using SN-38-incorporated polymeric microparticle. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms22115557","DOI":"10.3390\/ijms22115557"},{"key":"12329_CR20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13046-018-0894-0","volume":"37","author":"M Lu","year":"2018","unstructured":"Lu M, Yu S, Deng M (2018) AKBA inhibits glioblastoma cell proliferation and induces apoptosis via downregulating FOXM1. J Exp Clin Cancer Res 37:220","journal-title":"J Exp Clin Cancer Res"},{"key":"12329_CR21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","volume":"83","author":"DJ Newman","year":"2020","unstructured":"Newman DJ, Cragg GM (2020) Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019. J Nat Prod 83:770\u2013803","journal-title":"J Nat Prod"},{"key":"12329_CR22","doi-asserted-by":"crossref","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107783","volume":"221","author":"Q Wang","year":"2021","unstructured":"Wang Q et al (2021) Glioblastoma multiforme: Clinical challenges and emerging therapeutic strategies. Pharmacol Ther 221:107753","journal-title":"Pharmacol Ther"},{"key":"12329_CR23","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3390\/ph18111725","volume":"18","author":"S Genc","year":"2025","unstructured":"Genc S, Nadaroglu H, Cinar R, Nigde E, Karabulut K, Taghizadehghalehjoughi A (2025) New anti-cancer impact of cerium oxide, lithium, and Sn-38 synergy via DNA methylation-mediated reduction of MMP-2 and modulation of the PI3K\/Akt\/mTOR Pathway. Pharmaceuticals 18:1725","journal-title":"Pharmaceuticals"},{"key":"12329_CR24","doi-asserted-by":"publisher","first-page":"e2102816","DOI":"10.1002\/adhm.202102816","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Xie M, Jones JB, Zhang Z, Wang Z, Dang T, Wang X, Lipowska M, Mao H (2022) Targeted delivery of DNA topoisomerase inhibitor SN38 to intracranial tumors of glioblastoma using Sub-5 ultrafine iron oxide nanoparticles. Adv Healthc Mater 11:e2102816. https:\/\/doi.org\/10.1002\/adhm.202102816","journal-title":"Adv Healthc Mater"},{"key":"12329_CR25","doi-asserted-by":"publisher","unstructured":"Yeni Y, Genc S, Ertugrul MS, Nadaroglu H, Gezer A, Mendil AS, Hacimuftuoglu A (2024) Neuroprotective effects of L-Dopa-modified zinc oxide nanoparticles on the rat model of 6-OHDA-\u0131nduced Parkinson\u2019s disease. Sci Rep-Uk 14, doi:ARTN 19077 https:\/\/doi.org\/10.1038\/s41598-024-69324-4","DOI":"10.1038\/s41598-024-69324-4"},{"key":"12329_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","volume":"74","author":"ZN Oltvai","year":"1993","unstructured":"Oltvai ZN, Milliman CL, Korsmeyer SJ (1993) Bcl-2 Heterodimerizes in-vivo with a conserved homolog, bax, that accelerates programmed cell-death. Cell 74:609\u2013619. https:\/\/doi.org\/10.1016\/0092-8674(93)90509-O","journal-title":"Cell"},{"key":"12329_CR27","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/42867","volume":"387","author":"JC Reed","year":"1997","unstructured":"Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387:773\u2013776. https:\/\/doi.org\/10.1038\/42867","journal-title":"Nature"},{"key":"12329_CR28","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/cyto.10091","volume":"50","author":"AB Schiller","year":"2002","unstructured":"Schiller AB, Clark WS, Cotsonis G, Lawson D, DeRose PB, Cohen C (2002) Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis. Cytometry 50:203\u2013209. https:\/\/doi.org\/10.1002\/cyto.10091","journal-title":"Cytometry"},{"key":"12329_CR29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9:798\u2013809. https:\/\/doi.org\/10.1038\/nrc2734","journal-title":"Nat Rev Cancer"},{"key":"12329_CR30","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1038\/sj.onc.1203551","volume":"19","author":"T Hirano","year":"2000","unstructured":"Hirano T, Ishihara K, Hibi M (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19:2548\u20132556. https:\/\/doi.org\/10.1038\/sj.onc.1203551","journal-title":"Oncogene"},{"key":"12329_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ajmg.1398","volume":"106","author":"S Raha","year":"2001","unstructured":"Raha S, Robinson BH (2001) Mitochondria, oxygen free radicals, and apoptosis. Am J Med Genet 106:62\u201370. https:\/\/doi.org\/10.1002\/ajmg.1398","journal-title":"Am J Med Genet"},{"key":"12329_CR32","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1054\/bjoc.2000.1455","volume":"83","author":"JF Mirjolet","year":"2000","unstructured":"Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL (2000) Bcl-2\/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status. Br J Cancer 83:1380\u20131386. https:\/\/doi.org\/10.1054\/bjoc.2000.1455","journal-title":"Br J Cancer"},{"key":"12329_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0250-474x.93507","volume":"73","author":"MZ Siddiqui","year":"2011","unstructured":"Siddiqui MZ (2011) Boswellia serrata, a potential antiinflammatory agent: An overview. Indian J Pharm Sci 73:255\u2013261. https:\/\/doi.org\/10.4103\/0250-474x.93507","journal-title":"Indian J Pharm Sci"},{"key":"12329_CR34","doi-asserted-by":"publisher","first-page":"1187181","DOI":"10.3389\/fphar.2023.1187181","volume":"14","author":"VL Trivedi","year":"2023","unstructured":"Trivedi VL, Soni R, Dhyani P, Sati P, Tejada S, Sureda A, Setzer WN, Faizal Abdull Razis A, Modu B, Butnariu M et al (2023) Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent. Front Pharmacol 14:1187181. https:\/\/doi.org\/10.3389\/fphar.2023.1187181","journal-title":"Front Pharmacol"},{"key":"12329_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radical Bio Med 48:749\u2013762. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.12.022","journal-title":"Free Radical Bio Med"},{"key":"12329_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/0192623309356453","volume":"38","author":"JE Klaunig","year":"2010","unstructured":"Klaunig JE, Kamendulis LM, Hocevar BA (2010) Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol 38:96\u2013109. https:\/\/doi.org\/10.1177\/0192623309356453","journal-title":"Toxicol Pathol"},{"key":"12329_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1746-1596-9-92","volume":"9","author":"JR Eidet","year":"2014","unstructured":"Eidet JR, Pasovic L, Maria R, Jackson CJ, Utheim TP (2014) Objective assessment of changes in nuclear morphology and cell distribution following induction of apoptosis. Diagn Pathol 9:92. https:\/\/doi.org\/10.1186\/1746-1596-9-92","journal-title":"Diagn Pathol"},{"key":"12329_CR38","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342\u2013348. https:\/\/doi.org\/10.1038\/35077213","journal-title":"Nature"},{"key":"12329_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I Vermes","year":"1995","unstructured":"Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C (1995) A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184:39\u201351. https:\/\/doi.org\/10.1016\/0022-1759(95)00072-I","journal-title":"J Immunol Methods"},{"key":"12329_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K (2019) Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol 20:175\u2013193. https:\/\/doi.org\/10.1038\/s41580-018-0089-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12329_CR41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrc883","volume":"2","author":"S Cory","year":"2002","unstructured":"Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647\u2013656. https:\/\/doi.org\/10.1038\/nrc883","journal-title":"Nat Rev Cancer"},{"key":"12329_CR42","doi-asserted-by":"publisher","unstructured":"Fu W, Hou X, Dong L, Hou W (2023) Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Front Cell Dev Biology Volume 11\u20132023. https:\/\/doi.org\/10.3389\/fcell.2023.1098482","DOI":"10.3389\/fcell.2023.1098482"},{"key":"12329_CR43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ccr.2006.03.030","volume":"9","author":"J Lee","year":"2006","unstructured":"Lee J, Kotliarova S, Kotliarov Y, Li AG, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W et al (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391\u2013403. https:\/\/doi.org\/10.1016\/j.ccr.2006.03.030","journal-title":"Cancer Cell"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12329-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:42:16Z","timestamp":1783604536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12329-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12329"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12329-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"1124"}}